Protective effect of chrysoeriol against doxorubicin-induced cardiotoxicity in vitro

Chinese Medical Journal

Volumn 122, Issue 21, 2009, Pages 2652-2656

  Liu, Zhe ^a   Song, Xiao Dong ^a   Xin, Ying ^a   Wang, Xiao Jian ^a   Yu, Hui ^a   Bai, Yong Yi ^a   Liu, Jun Hao ^a   Zhang, Chan Na ^a   Hui, Ru Tai ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Cardiotoxicity; Chrysoeriol; Doxorubicin; Reactive oxygen species

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CHRYSOERIOL; DOXORUBICIN; FLAVONE DERIVATIVE; GLUTATHIONE PEROXIDASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CELL DEATH; CELL STRAIN; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; FEMALE; HEART PROTECTION; HELA CELL; IMMUNOASSAY; IMMUNOFLUORESCENCE; IN VITRO STUDY; NONHUMAN; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE; CELL SURVIVAL; DOXORUBICIN; FLAVONOIDS; GLUTATHIONE PEROXIDASE; HEART; HELA CELLS; HUMANS; L-LACTATE DEHYDROGENASE; MOLECULAR STRUCTURE; MYOCYTES, CARDIAC; RATS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 73449117216     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.21.024     Document Type: Article

References (19)

1. Bryant J, Picot J, Levitt G, Sullivan I, Baxter L, Clegg A. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. Health Technol Assess 2007; 11: 1-84.
2. Takemura G, Fujiwara H. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 2007; 49: 330-352.
3. Menna P, Minotti G, Salvatorelli E. In vitro modeling of the structure-activity determinants of anthracycline cardiotoxicity. Cell Biol Toxicol 2007; 23: 49-62.
4. Elbl L, Hrstkova H, Tomaskova I, Michalek J. Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up. Support Care Cancer 2006; 14: 128-136.
5. Wouters KA, Kremer LC, Miller TL, Herman EH, Lipshultz SE. Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies. Br J Haematol 2005; 131: 561-578.
6. Choi DY, Lee JY, Kim MR, Woo ER, Kim YG, Kang KW. Chrysoeriol potently inhibits the induction of nitric oxide synthase by blocking AP-1 activation. J Biomed Sci 2005; 12: 949-959.
7. Moscatelli V, Hnatyszyn O, Acevedo C, Megías J, Alcaraz MJ, Ferraro G. Flavonoids from Artemisia copa with anti-inflammatory activity. Planta Med 2006; 72: 72-74.
8. Choi CW, Jung HA, Kang SS, Choi JS. Antioxidant constituents and a new triterpenoid glycoside from Flos Lonicerae. Arch Pharm Res 2007; 30: 1-7.
9. Schinella GR, Giner RM, Recio MC, Mordujovich de Buschiazzo P, Ríos JL, Máñez S. Anti-inflammatory effects of South American Tanacetum vulgare. J Pharm Pharmacol 1998; 50: 1069-1074.
10. Abu Zarga M, Qauasmeh R, Sabri S, Munsoor M, Abdalla S. Chemical constituents of Artemisia arborescens and the effect of the aqueous extract on rat isolated smooth muscle. Planta Med 1995; 61: 242-245.
11. Han LK, Sumiyoshi M, Zheng YN, Okuda H, Kimura Y. Anti-obesity action of Salix matsudana leaves (Part 2). Isolation of anti-obesity effectors from polyphenol fractions of Salix matsudana. Phytother Res 2003; 17: 1195-1198.
12. Mishra B, Priyadarsini KI, Kumar MS, Unnikrishnan MK, Mohana H. Effect of O-glycosilation on the antioxidant activity and free radical reactions of a plant flavonoid, chrysoeriol. Bioorg Med Chem 2003; 11: 2677-2685.
13. Fukuda M, Tsuchihashi Y, Takamatsu T, Nakanishi K, Fujita S. Fluorescence fading and stabilization in cytofluorometry. Histochemistry 1980; 65: 269-276.
14. Shao ZH, Li CQ, Vanden Hoek TL, Becker LB, Schumacker PT, Wu JA, et al. Extract from Scutellaria baicalensis Georgi attenuates oxidant stress in cardiomyocytes. J Mol Cell Cardiol 1999; 31: 1885-1895.
15. Iqbal J, Whitney P. Use of cyanide and diethyldithiocarbamate in the assay of superoxide dismutases. Free Radic Biol Med 1991; 10: 69-77.
16. Richard MJ, Portal B, Meo J, Coudray C, Hadjian A, Favier A. Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin Chem 1992; 38: 704-709.
17. Tokarska-Schlattner M, Zaugg M, Zuppinger C, Wallimann T, Schlattner U. New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics. J Mol Cell Cardiol 2006; 41: 389-405.
18. Bast A, Haenen GR, Bruynzeel AM, Van der Vijgh WJ. Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials. Cardiovasc Toxicol 2007; 7: 154-159.
19. Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 1999; 27: 612-616.